JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇸🇪
Cannabis — RestrictedEurope

Sweden

Sweden maintains one of Europe's most restrictive cannabis policies, with a zero-tolerance approach to all drug use including cannabis. Medical cannabis is technically available through the Narcotic Drugs Act but access is extremely limited, with Sativex being the only approved cannabis-based medicine and very few patients receiving prescriptions.

Ask the Expert about Sweden
Regulator
Lakemedelsverket
Key Legislation
Narkotikastrafflagen
Year Legalized
2012 (Sativex approved for limited medical use)
Program Size
Extremely limited; only Sativex appro...

Key Facts

  • Sweden follows a strict zero-tolerance drug policy, and even personal cannabis use is a criminal offense punishable by fines or up to 6 months imprisonment
  • Sativex (nabiximols) was approved in 2012 for MS-related spasticity, making it the only cannabis-based medicine with market authorization
  • Swedish drug policy emphasizes abstinence and prevention, with mandatory drug testing in workplaces and schools being relatively common
  • Hemp cultivation is permitted under EU regulations with THC below 0.2%, but the Swedish market for hemp products remains small
  • Public opinion polls show growing support for cannabis reform, particularly among younger Swedes, though political parties remain largely opposed

Key Legislation

Narkotikastrafflagen (Narcotics Drugs Punishment Act, 1968:64); Lag om kontroll av narkotika (Narcotics Control Act, 1992:860)

Regulatory Body

Lakemedelsverket (Swedish Medical Products Agency - MPA)

Country Info
ISO Code
SE
Region
Europe
Tier
Tier 3 — Restricted
Status
Cannabis — Restricted
Sources
Lakemedelsverket - Swedish Medical Products AgencyFolkhalsomyndigheten - Public Health Agency of Sweden
Disclaimer: This information is for general reference only and does not constitute legal advice. Cannabis regulations change frequently. Always verify with official sources and local legal counsel before making compliance decisions.